About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2023 Corporate Membership Program at ‘Champion’ Level

By: via GlobeNewswire

ROCKVILLE, Md., Oct. 06, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim and Eli Lilly and Company have joined the 2023 class in AKF’s Corporate Membership Program as a Champion-level member. Boehringer Ingelheim and Lilly’s membership helps fund AKF’s work to advance kidney disease awareness, prevention, early detection, treatment and research.

“AKF is pleased to continue our partnership with Boehringer Ingelheim and Lilly in the fight against kidney disease,” said LaVarne A. Burton, AKF President and CEO. “We are particularly grateful for their support for our kidney health equity programs, including our Kidney Health for All campaign, which addresses the most pressing racial gaps in kidney disease care. Through Boehringer Ingelheim and Lilly’s generosity, the Kidney Health for All campaign has launched a microsite that shares programs and resources that put solutions into practice to help all people equally prevent and get treatment for kidney disease.”

Boehringer Ingelheim and Lilly have supported AKF’s annual Kidney Action Week, a free, virtual week-long summit that offers information, tools and resources to prevent, detect and manage kidney disease. They also generously contribute to AKF’s key kidney disease prevention and education initiative Know Your Kidneys™. This signature educational campaign includes downloadable guides on preventing and managing kidney disease as well as doctor discussion guides to encourage patients to start critical conversations with their health care teams to protect their kidneys before and after a kidney disease diagnosis.

“Boehringer Ingelheim and Lilly are proud to continue to champion the work of the AKF by joining the Corporate Membership Program for the second consecutive year,” said Brian DiDonato, Senior Vice President, Cardio-Renal-Metabolic Brands at Boehringer Ingelheim. “We remain committed to partnering with organizations such as AKF to create innovative and meaningful programs and resources that help reach the millions of people both living with and at risk of developing kidney disease in the U.S.”

By joining the Corporate Membership Program, Boehringer Ingelheim and Lilly are helping to fund AKF’s award-winning educational programs and resources.

The Corporate Membership Program is open to institutional partners that support AKF’s mission of fighting kidney disease and helping people live healthier lives. For more information, contact Daniel Green, corporate engagement manager, at dgreen@kidneyfund.org or 301-984-6675.

About the American Kidney Fund

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. One of the nation’s top-rated nonprofits, AKF invests 97 cents of every donated dollar in programs, earning the highest 4-Star rating from Charity Navigator for 20 years in a row as well as the Platinum Seal of Transparency from Candid, formerly GuideStar.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.


Nancy Gregory
American Kidney Fund
(240) 292-7077
ngregory@kidneyfund.org

More News

View More
After Gold Blast Soars Past $4,000, BofA Eyes $5,000 in 2026
Via MarketBeat
Tickers AEM B BAC GDX GDXJ GLD
Buyback Boom: 3 Companies Betting Big on Themselves
Via MarketBeat
Tickers AZO ESTC LMT
Analysts Flock to Upgrade DELL After Big AI-Server Guidance Boost
Via MarketBeat
Topics Artificial Intelligence
Tickers DELL MSFT
Amazon Is on the Cusp of Becoming a Grocery Disruptor
Via MarketBeat
Tickers ACI AMZN COST KR WMT
Pure Storage Hits New High: AI’s Under-the-Radar Powerhouse
Via MarketBeat
Topics Artificial Intelligence
Tickers CRWD IT MSFT PSTG
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.